Browse by Poster Presenter

Skip to main content

2022 IKCS: Europe Main banner

Tweets by 2022 IKCS: Europe

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

C
Carril-Ajuria, Lucia

Institute Gustave Roussy, Villejuif, France. University Hospital 12 de Octubre, Madrid, Spain.
12: Efficacy of frontline combination therapy in metastatic renal cell carcinoma (mRCC) patients (pts) with poor performance status (PS)
Lucia Carril-Ajuria
Favorite
23: Relationship between circulating immune markers and tertiary lymphoid structures (TLS) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with nivolumab within the NIVOREN study.
Lucia Carril-Ajuria
Favorite
24: Circulating microRNAs and treatment response to cabozantinib in metastatic clear cell renal cell carcinoma (mRCC) patients treated in the phase II CABOPRE trial.
Lucia Carril-Ajuria
Favorite